Home / Stocks / LTRN

LTRN insider trading

Lantern Pharma Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$200k
Buys · last 90 days
0 · $0
Most recent buy
2026-05-14

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-14Schalop Lee Troy
Director
Bought48,544$2.06$100k
2026-05-14KEYSER D JEFFREY
Director
Bought48,544$2.06$100k

Most active insider buyers

InsiderRoleBuysTotal bought
Schalop Lee TroyDirector1$100k
KEYSER D JEFFREYDirector1$100k

See LTRN on the chart

Every insider buy and sell for LTRN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.